Compound ID | 179

BC-9538

Class: Pleuromutilin

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: S. aureus (MSSA, MRSA) and S. pneumoniae, along with E.coli, K.pneumoniae and E.cloacae
Propensity to select resistant mutants: Yes
Institute where first reported: Nabriva Therapeutics, Austria
Year first mentioned: 2010
Highest developmental phase: Preclinical
Development status: Active

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.